| User's Publication |
|
20382
Fan M, Arai M, Tawada A, Chiba T, Fukushima R, Uzawa K, Shiiba M, Kato N, Tanzawa H, Takiguchi Y.
Contrasting functions of the epithelial‑stromal interaction 1 gene, in human oral and lung squamous cell cancers.
Oncol Rep
2022
47(1)
PubMed ID: 34738627
DOI: 10.3892/or.2021.8216
|
|
20513
Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Katada A, Hayashi T, Kobayashi H, Harabuchi Y.
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma.
Oncoimmunology
2022
11(1):2021619
PubMed ID: 35003900
DOI: 10.1080/2162402X.2021.2021619
|
|
20544
Matsuda R, Sakagami H, Amano S, Iijima Y, Sano M, Uesawa Y, Tamura N, Oishi Y, Takeshima H.
Inhibition of Neurotoxicity/Anticancer Activity of Bortezomib by Caffeic Acid and Chlorogenic Acid.
Anticancer Res
2022
42(2):781-790
PubMed ID: 35093876
DOI: 10.21873/anticanres.15536
|
|
16180
Katsuhiro Asaka, Akira Fukatsu, Chiaki Komine
The Effectiveness of a Portable Fluorescence Spectrophotometer for Early Detection of Oral Cancer
Open Journal of Stomatology
2022
12:30-31
DOI: 10.4236/ojst.2022.121003
|
|
16203
Sasabe E, Tomomura A, Liu H, Sento S, Kitamura N, Yamamoto T.
Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis
Cancer Sci
2022
113(2):609-621
PubMed ID: 34874595
DOI: 10.1111/cas.15225
|
|
20648
Naitoh K, Orihara Y, Sakagami H, Miura T, Satoh K, Amano S, Bandow K, Iijima Y, Kurosaki K, Uesawa Y, Hashimoto M, Wakabayashi H.
Tumor-Specificity, Neurotoxicity, and Possible Involvement of the Nuclear Receptor Response Pathway of 4,6,8-Trimethyl Azulene Amide Derivatives.
Int J Mol Sci
2022
23(5)
PubMed ID: 35269748
DOI: 10.3390/ijms23052601
|
|
20815
Hossain M, Roayapalley PK, Sakagami H, Satoh K, Bandow K, Das U, Dimmock JR.
Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells.
Medicines (Basel)
2022
9(6)
PubMed ID: 35736248
DOI: 10.3390/medicines9060035
|
|
17100
Izumi A, Yamamoto K, Kawaguchi M, Yamashita F, Fukushima T, Kiwaki T, Tanaka H, Yamashita Y, Kataoka H.
Insufficiency of hepatocyte growth factor activator inhibitor-1 confers lymphatic invasion of tongue carcinoma cells
Cancer Sci
2022
113(6):2179-2193
PubMed ID: 35332604
DOI: 10.1111/cas.15346
|
|
20884
Shindo A, Kusano M, Sakagami H, Amano S, Inomata M, Abe M, Okazawa M, Ooka T.
Comparison of UVC Sensitivity and Dectin-2 Expression Between Malignant and Non-malignant Cells.
In Vivo
2022
36(5):2116-2125
PubMed ID: 36099100
DOI: 10.21873/invivo.12937
|
|
20932
Katase N, Nishimatsu SI, Yamauchi A, Okano S, Fujita S.
Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC).
Cancer Cell Int
2022
22(1):352
PubMed ID: 36376957
DOI: 10.1186/s12935-022-02783-9
|
|
20970
Murakami K, Umemura N, Adachi M, Motoki M, Ohkoshi E.
ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells.
Exp Ther Med
2022
24(6):722
PubMed ID: 36340608
DOI: 10.3892/etm.2022.11658
|
|
20085
Kase Y, Uzawa K, Wagai S, Yoshimura S, Yamamoto JI, Toeda Y, Okubo M, Eizuka K, Ando T, Nobuchi T, Kawasaki K, Saito T, Iyoda M, Nakashima D, Kasamatsu A, Tanzawa H.
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
Sci Rep
2021
11(1):5897
PubMed ID: 33723306
DOI: 10.1038/s41598-021-85242-1
|
|
20133
Nakamura A, Kakihara Y, Funayama A, Haga K, Mikami T, Kobayashi D, Yoshida Y, Izumi K, Kobayashi T, Saeki M.
HEATR1, a novel interactor of Pontin/Reptin, stabilizes Pontin/Reptin and promotes cell proliferation of oral squamous cell carcinoma.
Biochem Biophys Res Commun
2021
557:294-301
PubMed ID: 33894417
DOI: 10.1016/j.bbrc.2021.04.021
|
|
14869
Torii C, Maishi N, Kawamoto T, Morimoto M, Akiyama K, Yoshioka Y, Minami T, Tsumita T, Alam MT, Ochiya T, Hida Y, Hida K.
miRNA-1246 in extracellular vesicles secreted from metastatic tumor induces drug resistance in tumor endothelial cells
Sci Rep
2021
11(1):13502
PubMed ID: 34226586
DOI: 10.1038/s41598-021-92879-5
|
|
20350
Haga K, Yamazaki M, Maruyama S, Kawaharada M, Suzuki A, Hoshikawa E, Chan NN, Funayama A, Mikami T, Kobayashi T, Izumi K, Tanuma JI.
Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF-β/SOX9 axis in cancer progression.
Transl Oncol
2021
14(12):101236
PubMed ID: 34624685
DOI: 10.1016/j.tranon.2021.101236
|
|
20406
Sawa C, Yofu S, Kiriyama K, Sutoh K, Saito T, Kishi S, Gunji M, Inoue Y, Sugi M, Shioda S, Honda K.
High concentration of extracellular nucleotides suppresses cell growth via delayed cell cycle progression in cancer and noncancer cell lines.
Heliyon
2021
7(11):e08318
PubMed ID: 34816032
DOI: 10.1016/j.heliyon.2021.e08318
|
|
20438
Yang KH, Tang JY, Chen YN, Chuang YT, Tsai IH, Chiu CC, Li LJ, Chien TM, Cheng YB, Chang FR, Yen CY, Chang HW.
Nepenthes Extract Induces Selective Killing, Necrosis, and Apoptosis in Oral Cancer Cells.
J Pers Med
2021
11(9)
PubMed ID: 34575651
DOI: 10.3390/jpm11090871
|
|
15868
Itashiki Y, Harada K, Takenawa T, Ferdous T, Ueyama Y, Mishima K.
Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
Oncol Lett
2021
22(4):730
PubMed ID: 34429770
DOI: 10.3892/ol.2021.12991
|
|
16099
Saito K, Mitsui A, Sumardika IW, Yokoyama Y, Sakaguchi M, Kondo E.
PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1
Int J Oncol
2021
58(6):29
PubMed ID: 33887877
DOI: 10.3892/ijo.2021.5209
|
|
16112
Akyu Takei R, Tomihara K, Yamazaki M, Moniruzzaman R, Heshiki W, Sekido K, Tachinami H, Sakurai K, Yonesi A, Imaue S, Fujiwara K, Noguchi M.
Protumor role of estrogen receptor expression in oral squamous cell carcinoma cells
Oral Surg Oral Med Oral Pathol Oral Radiol
2021
132(5):549-565
PubMed ID: 34518137
DOI: 10.1016/j.oooo.2021.04.006
|
|
16136
Harada K, Ferdous T, Watanabe K, Mizukami Y, Mishima K.
Effects of an elemental diet, Elental®, may differ between healthy oral cells and oral cancer cells
Oncol Rep
2021
45(2):738-751
PubMed ID: 33416174
DOI: 10.3892/or.2020.7896
|
|
16138
Ando T, Kasamatsu A, Kawasaki K, Hiroshima K, Fukushima R, Iyoda M, Nakashima D, Endo-Sakamoto Y, Uzawa K.
Tumor Suppressive Circular RNA-102450: Development of a Novel Diagnostic Procedure for Lymph Node Metastasis from Oral Cancer
Cancers (Basel)
2021
13(22):5708
PubMed ID: 34830863
DOI: 10.3390/cancers13225708
|
|
16139
Kase-Kato I, Asai S, Minemura C, Tsuneizumi K, Oshima S, Koma A, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Molecular Pathogenesis of the Coronin Family: CORO2A Facilitates Migration and Invasion Abilities in Oral Squamous Cell Carcinoma
Int J Mol Sci
2021
22(23):12684
PubMed ID: 34884487
DOI: 10.3390/ijms222312684
|
|
16173
Suzuka J, Tsuda M, Wang L, Kohsaka S, Kishida K, Semba S, Sugino H, Aburatani S, Frauenlob M, Kurokawa T, Kojima S, Ueno T, Ohmiya Y, Mano H, Yasuda K, Gong JP, Tanaka S.
Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels
Nat Biomed Eng
2021
5(8):914-925
PubMed ID: 33782572
DOI: 10.1038/s41551-021-00692-2
|
|
16196
Sakagami H, Furukawa T, Satoh K, Amano S, Iijima Y, Koshikawa T, Asai D, Fukuchi K, Takemura H, Kanamoto T, Yokose S.
Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue
Medicines (Basel)
2021
8(7):33
PubMed ID: 34206186
DOI: 10.3390/medicines8070033
|
|
16206
Koma A, Asai S, Minemura C, Oshima S, Kinoshita T, Kikkawa N, Koshizuka K, Moriya S, Kasamatsu A, Hanazawa T, Uzawa K, Seki N.
Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma
Int J Mol Sci
2021
22(18):9947
PubMed ID: 34576110
DOI: 10.3390/ijms22189947
|
|
16862
Kawasaki M, Sakabe T, Kodani I, Umekita Y.
Cytoplasmic-only Expression of Maspin Predicts Poor Prognosis in Patients With Oral Squamous Cell Carcinoma
Anticancer Res
2021
41(9):4563-4570
PubMed ID: 34475084
DOI: 10.21873/anticanres.15269
|
|
16975
Hotta H, Hamamura K, Shibuya H, Ohmi Y, Furukawa K, Furukawa K.
Lewis y Expressed in Oral Squamous Cell Carcinoma Attenuates Malignant Properties via Down-regulation of EGF Signaling
Anticancer Res
2021
41(4):1821-1830
PubMed ID: 33813387
DOI: 10.21873/anticanres.14948
|
|
11844
Sakurai K, Tomihara K, Yamazaki M, Heshiki W, Moniruzzaman R, Sekido K, Tachinami H, Ikeda A, Imaue S, Fujiwara K, Noguchi M.
CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity.
Oral Dis
2020
26(4):745-755
PubMed ID: 31603606
DOI: 10.1111/odi.13210
|
|
11965
Fujii S, Tajiri Y, Hasegawa K, Matsumoto S, Yoshimoto RU, Wada H, Kishida S, Kido MA, Yoshikawa H, Ozeki S, Kiyoshima T.
The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation.
Lab. Invest.
2020
PubMed ID: 31857698
DOI: 10.1038/s41374-019-0357-z
|
|
13013
Nakaya G, Sakagami H, Koga-Ogawa Y, Shiroto A, Nobesawa T, Ueda D, Nakatani S, Kobata K, Iijima Y, Tone S, David-Gonzalez A, Garcia-Contreras R, Tomomura M, Kito S, Tamura N, Takeshima H.
Augmentation of Neurotoxicity of Anticancer Drugs by X-Ray Irradiation.
In Vivo
2020
PubMed ID: 32354886
DOI: 10.21873/invivo.11869
|
|
13093
Iijima Y, Bandow K, Amano S, Sano M, Hino S, Kaneko T, Horie N, Sakagami H.
Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
Anticancer Res
2020
PubMed ID: 32620607
DOI: 10.21873/anticanres.14357
|
|
13148
Tang JY, Wu KH, Wang YY, Farooqi AA, Huang HW, Yuan SF, Jian RI, Tsao LY, Chen PA, Chang FR, Cheng YB, Hu HC, Chang HW.
Methanol Extract of Usnea barbata Induces Cell Killing, Apoptosis, and DNA Damage against Oral Cancer Cells through Oxidative Stress.
Antioxidants (Basel)
2020
PubMed ID: 32756347
DOI: 10.3390/antiox9080694
|
|
13205
Teratani M, Nakamura S, Sakagami H, Fujise M, Hashimoto M, Okudaira N, Bandow K, Iijima Y, Nagai J, Uesawa Y, Wakabayashi H.
Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro.
Anticancer Res
2020
PubMed ID: 32878776
DOI: 10.21873/anticanres.14491
|
|
13401
Hayashi R, Nagato T, Kumai T, Ohara K, Ohara M, Ohkuri T, Hirata-Nozaki Y, Harabuchi S, Kosaka A, Nagata M, Yajima Y, Yasuda S, Oikawa K, Kono M, Kishibe K, Takahara M, Katada A, Hayashi T, Celis E, Harabuchi Y, Kobayashi H.
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma.
Oncoimmunology
2020
PubMed ID: 33457076
DOI: 10.1080/2162402X.2020.1856545
|
|
13783
Otsuki Y, Yamasaki J, Suina K, Okazaki S, Koike N, Saya H, Nagano O.
Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy
Cancer Sci
2020
111(1):127-136.
PubMed ID: 31692172
DOI: 10.1111/cas.14224
|
|
13892
Nguyen CTK, Sawangarun W, Mandasari M, Morita KI, Harada H, Kayamori K, Yamaguchi A, Sakamoto K.
AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression
PLoS One
2020
15(2):e0222689
PubMed ID: 32012175
DOI: 10.1371/journal.pone.0222689
|
|
13903
Aika Tanzawa et al.
Comprehensive gene expression analysis of semaphorins in oral squamous cell carcinoma
Oral Science International
2020
17(2):67-72
DOI: 10.1002/osi2.1044
|
|
13920
Kazutaka KIMURA, Yuichi OHNISHI, Tomoharu OKAMURA, Kazuya TOMINAGA, Masahiro NAKAJIMA
Effect of HGF/c-Met pathway in oral squamous cell carcinoma on EMT and metastatic potential
Journal of Osaka Dental University
2020
54(1):135-144
DOI: 10.18905/jodu.54.1_135
|
|
10691
Iwai S, Kishimoto S, Amano Y, Nishiguchi A, Matsusaki M, Takeshita A, Akashi M.
Three-dimensional cultured tissue constructs that imitate human living tissue organization for analysis of tumor cell invasion.
J Biomed Mater Res A
2019
107(2):292-300
PubMed ID: 29280265
DOI: 10.1002/jbm.a.36319
|
|
11300
Shimizu R, Ibaragi S, Eguchi T, Kuwajima D, Kodama S, Nishioka T, Okui T, Obata K, Takabatake K, Kawai H, Ono K, Okamoto K, Nagatsuka H, Sasaki A.
Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
Int. J. Oncol.
2019
PubMed ID: 30431077
DOI: 10.3892/ijo.2018.4631
|
|
11350
Katase N, Nishimatsu SI, Yamauchi A, Yamamura M, Fujita S.
DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
Int. J. Oncol.
2019
PubMed ID: 30569110
DOI: 10.3892/ijo.2018.4667
|
|
11354
Nakamura Y, Nakahata S, Kondo Y, Izumi A, Yamamoto K, Ichikawa T, Tamura T, Noumi K, Yamashita Y, Morishita K.
Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 30587341
DOI: 10.1016/j.bbrc.2018.12.066
|
|
6020
Matsuo K, Suzuki H, Yatagai N, Enomoto Y, Kitayama M, Shigeoka M, Kimoto A, Matsumoto K, Komori T.
Red LED Light Is Influenced by IL-6 to Promote the Migration Ability of Oral Squamous Cell Carcinoma Cell Line.
Kobe J Med Sci
2019
64(6):E210-E216
PubMed ID: 31327864
|
|
11584
Tang JY, Peng SY, Cheng YB, Wang CL, Farooqi AA, Yu TJ, Hou MF, Wang SC, Yen CH, Chan LP, Ou-Yang F, Chang HW.
Ethyl acetate extract of Nepenthes adrianii x clipeata induces antiproliferation, apoptosis, and DNA damage against oral cancer cells through oxidative stress.
Environ. Toxicol.
2019
PubMed ID: 31157515
DOI: 10.1002/tox.22748
|
|
11590
Tang JY, Li LJ, Ou-Yang F, Wang CL, Shu CW, Wu KH, Wang HR, Yen CH, Cheng YB, Chang HW.
Ethyl Acetate Extract of Nepenthes ventricosa x maxima Exerts Preferential Killing to Oral Cancer Cells.
DNA Cell Biol.
2019
PubMed ID: 31170002
DOI: 10.1089/dna.2018.4436
|
|
11620
Imanari K, Hashimoto M, Wakabayashi H, Okudaira N, Bandow K, Nagai J, Tomomura M, Tomomura A, Uesawa Y, Sakagami H.
Quantitative Structure-Cytotoxicity Relationship of Azulene Amide Derivatives.
Anticancer Res.
2019
PubMed ID: 31262875
DOI: 10.21873/anticanres.13497
|
|
11759
Uzawa K, Amelio AL, Kasamatsu A, Saito T, Kita A, Fukamachi M, Sawai Y, Toeda Y, Eizuka K, Hayashi F, Kato-Kase I, Sunohara M, Iyoda M, Koike K, Nakashima D, Ogawara K, Endo-Sakamoto Y, Shiiba M, Takiguchi Y, Yamauchi M, Tanzawa H.
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.
Sci Rep
2019
PubMed ID: 31434965
DOI: 10.1038/s41598-019-48717-w
|
|
9696
Kazuya Hiroshima, Masashi Shiiba, Noritoshi Oka, Fumihiko Hayashi, Sho Ishida, Reo Fukushima, Kazuyuki Koike, Manabu Iyoda, Dai Nakashima, Hideki Tanzawa, Katsuhiro Uzawa
Tspan15 Plays a Crucial Role in Metastasis in Oral Squamous Cell Carcinoma
Exp Cell Res
2019
384(2):111622
PubMed ID: 31518558
DOI: 10.1016/j.yexcr.2019.111622
|
|
9810
Junko Shibato, Fumiko Takenoya, Takahiro Hirabayashi, Ai Kimura, Yusuke Iwasaki, Yoko Toyoda, Motohide Hori, Shigeru Tamogami, Randeep Rakwal, Seiji Shioda
Towards Identification of Bioactive Compounds in Cold Vacuum Extracted Double Cherry Blossom (Gosen-Sakura) Leaves
Plant Signal Behav
2019
14(10):e1644594
PubMed ID: 31342859
DOI: 10.1080/15592324.2019.1644594
|
|
9890
Noritoshi Oka, Atsushi Kasamatsu, Yosuke Endo-Sakamoto, Keitaro Eizuka, Sho Wagai, Nao Koide-Ishida, Isao Miyamoto, Manabu Iyoda, Hideki Tanzawa, Katsuhiro Uzawa
Centromere Protein N Participates in Cellular Proliferation of Human Oral Cancer by Cell-Cycle Enhancement
J Cancer
2019
10(16):3728-3734
PubMed ID: 31333790
DOI: 10.7150/jca.32281
|
|
11907
Cervino G, Fiorillo L, Herford AS, Romeo U, Bianchi A, Crimi S, D'Amico C, De Stefano R, Troiano G, Santoro R, Laino L, Laino G, Cicciù M.
Molecular Biomarkers Related to Oral Carcinoma: Clinical Trial Outcome Evaluation in a Literature Review.
Dis. Markers
2019
PubMed ID: 31019584
DOI: 10.1155/2019/8040361
|
|
11931
Iijima Y, Bandow K, Sano M, Hino S, Kaneko T, Horie N, Sakagami H.
In Vitro Assessment of Antitumor Potential and Combination Effect of Classical and Molecular-targeted Anticancer Drugs.
Anticancer Res.
2019
PubMed ID: 31810932
DOI: 10.21873/anticanres.13882
|
|
11933
Nagai J, Shi H, Sezaki N, Yoshida N, Bandow K, Uesawa Y, Sakagami H, Tomomura M, Tomomura A, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 2-Arylazolylchromones and 2-Triazolylchromones.
Anticancer Res.
2019
PubMed ID: 31810912
DOI: 10.21873/anticanres.13862
|
|
12457
Eizuka K, Nakashima D, Oka N, Wagai S, Takahara T, Saito T, Koike K, Kasamatsu A, Shiiba M, Tanzawa H, Uzawa K.
SYT12 plays a critical role in oral cancer and may be a novel therapeutic target
J Cancer
2019
10(20):4913-4920
PubMed ID: 31598163
DOI: 10.7150/jca.32582
|
|
12459
Krishnan NM, Katoh H, Palve V, Pareek M, Sato R, Ishikawa S, Panda B.
Functional genomics screen with pooled shRNA library and gene expression profiling with extracts of Azadirachta indica identify potential pathways for therapeutic targets in head and neck squamous cell carcinoma
PeerJ
2019
7:e6464
PubMed ID: 30842898
DOI: 10.7717/peerj.6464
|
|
12460
Nozaki M, Yabuta N, Fukuzawa M, Mukai S, Okamoto A, Sasakura T, Fukushima K, Naito Y, Longmore GD, Nojima H.
LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer
Oncotarget
2019
10(10):1014-1030
PubMed ID: 30800215
DOI: 10.18632/oncotarget.26583
|
|
12586
Sato K, Shi L, Ito F, Ohara Y, Motooka Y, Tanaka H, Mizuno M, Hori M, Hirayama T, Hibi H, Toyokuni S.
Non-thermal plasma specifically kills oral squamous cell carcinoma cells in a catalytic Fe(II)-dependent manner
J Clin Biochem Nutr
2019
65(1):8-15
PubMed ID: 31379408
DOI: 10.3164/jcbn.18-91
|
|
10649
Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y, Seki N.
Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Auris Nasus Larynx
2018
45:854-865
PubMed ID: 29233721
DOI: 10.1016/j.anl.2017.11.019
|
|
10664
Ohnishi Y, Yasui H, Nozaki M, Nakajima M.
Molecularly-targeted therapy for the oral cancer stem cells.
Jpn Dent Sci Rev
2018
54:88-103
PubMed ID: 29755619
DOI: 10.1016/j.jdsr.2017.11.001
|
|
10668
Ikehata N, Takanashi M, Satomi T, Watanabe M, Hasegawa O, Kono M, Enomoto A, Chikazu D, Kuroda M.
Toll-like receptor 2 activation implicated in oral squamous cell carcinoma development.
Biochem. Biophys. Res. Commun.
2018
495:2227-2234
PubMed ID: 29269299
DOI: 10.1016/j.bbrc.2017.12.098
|
|
10724
Uesawa Y, Sakagami H, Okudaira N, Toda K, Takao K, Kagaya H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Cinnamic Acid Phenetyl Esters.
Anticancer Res.
2018
38:817-823
PubMed ID: 29374707
DOI: 10.21873/anticanres.12289
|
|
10806
Okubo Y, Kasamatsu A, Yamatoji M, Fushimi K, Ishigami T, Shimizu T, Kasama H, Shiiba M, Tanzawa H, Uzawa K.
Diacylglycerol lipase alpha promotes tumorigenesis in oral cancer by cell-cycle progression.
Exp. Cell Res.
2018
367:112-118
PubMed ID: 29614312
DOI: 10.1016/j.yexcr.2018.03.041
|
|
10829
Wada T, Maruyama R, Irie Y, Hashimoto M, Wakabayashi H, Okudaira N, Uesawa Y, Kagaya H, Sakagami H.
In Vitro Anti-tumor Activity of Azulene Amide Derivatives.
In Vivo
2018
32:479-486
PubMed ID: 29695549
DOI: 10.21873/invivo.11264
|
|
11110
Hara Y, Sakagami H, Shi H, Abe T, Tamura N, Takeshima H, Horie N, Kaneko T, Shiratsuchi H, Kaneko T.
Partial Protection of Paclitaxel-induced Neurotoxicity by Antioxidants.
In Vivo
2018
32(4):745-752
PubMed ID: 29936454
DOI: 10.21873/invivo.11303
|
|
11115
Shi H, Nagai J, Sakatsume T, Bandow K, Okudaira N, Sakagami H, Tomomura M, Tomomura A, Uesawa Y, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 2-(N-cyclicamino)chromone Derivatives.
Anticancer Res.
2018
38(7):3897-3906
PubMed ID: 29970510
DOI: 10.21873/anticanres.12674
|
|
11148
Shi H, Nagai J, Sakatsume T, Bandow K, Okudaira N, Uesawa Y, Sakagami H, Tomomura M, Tomomura A, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 3-(N-Cyclicamino)chromone Derivatives.
Anticancer Res.
2018
38(8):4459-4467
PubMed ID: 30061210
DOI: 10.21873/anticanres.12748
|
|
11226
Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.
J Cancer
2018
PubMed ID: 30271493
DOI: 10.7150/jca.25666
|
|
11306
Kakuguchi W, Nomura T, Kitamura T, Otsuguro S, Matsushita K, Sakaitani M, Maenaka K, Tei K.
Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells.
Cancer Med
2018
PubMed ID: 30449075
DOI: 10.1002/cam4.1877
|
|
4173
Uehara M, Minemura H, Ohno T, Hashimoto M, Wakabayashi H, Okudaira N, Sakagami H.
In Vitro Antitumor Activity of Alkylaminoguaiazulenes.
In Vivo
2018
PubMed ID: 29695558
DOI: 10.21873/invivo.11273
|
|
4235
Okazaki S, Shintani S, Hirata Y, Suina K, Semba T, Yamasaki J, Umene K, Ishikawa M, Saya H, Nagano O.
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.
Oncotarget
2018
PubMed ID: 30333913
DOI: 10.18632/oncotarget.26112
|
|
4236
Nanbu T, Umemura N, Ohkoshi E, Nanbu K, Sakagami H, Shimada J.
Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells.
Oncol. Rep.
2018
PubMed ID: 29192320
DOI: 10.3892/or.2017.6105
|
|
4237
Yamanouchi R, Harada K, Ferdous T, Ueyama Y.
Low carbonyl reductase 1 expression is associated with poor prognosis in patients with oral squamous cell carcinoma.
Mol Clin Oncol
2018
PubMed ID: 29456845
DOI: 10.3892/mco.2018.1548
|
|
4238
Sumi S, Umemura N, Adachi M, Ohta T, Naganawa K, Kawaki H, Takayama E, Kondoh N, Sumitomo S.
The luminance ratio of autofluorescence in a xenograft mouse model is stable through tumor growth stages.
Clin Exp Dent Res
2018
PubMed ID: 30386639
DOI: 10.1002/cre2.126
|
|
4239
Hong Y, He H, Sui W, Zhang J, Zhang S, Yang D.
Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Int. J. Oncol.
2018
PubMed ID: 29344674
DOI: 10.3892/ijo.2018.4247
|
|
4240
Jiaranuchart S, Kaida A, Onozato Y, Harada H, Miura M.
DNA damage response following X-irradiation in oral cancer cell lines HSC3 and HSC4.
Arch. Oral Biol.
2018
PubMed ID: 29522917
DOI: 10.1016/j.archoralbio.2018.02.016
|
|
4241
Sumita Y, Yamazaki M, Maruyama S, Abé T, Cheng J, Takagi R, Tanuma JI.
Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Oncol. Rep.
2018
PubMed ID: 30132562
DOI: 10.3892/or.2018.6665
|
|
4242
Daigo K, Takano A, Thang PM, Yoshitake Y, Shinohara M, Tohnai I, Murakami Y, Maegawa J, Daigo Y.
Characterization of KIF11 as a novel prognostic biomarker and therapeutic target for oral cancer.
Int. J. Oncol.
2018
PubMed ID: 29115586
DOI: 10.3892/ijo.2017.4181
|
|
14824
Chung MK, Jung YH, Lee JK, Cho SY, Murillo-Sauca O, Uppaluri R, Shin JH, Sunwoo JB.
CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug
Clin Cancer Res
2018
24(3):674-683
PubMed ID: 29208672
DOI: 10.1158/1078-0432.CCR-17-0866
|
|
14677
Yamamoto K, Kawaguchi M, Shimomura T, Izumi A, Konari K, Honda A, Lin CY, Johnson MD, Yamashita Y, Fukushima T, Kataoka H.
Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/ SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells
Oncotarget
2018
9(14):11691-11706.
PubMed ID: 29545930
DOI: 10.18632/oncotarget.24450
|
|
16201
Sawai Y, Kasamatsu A, Nakashima D, Fushimi K, Kasama H, Iyoda M, Kouzu Y, Shiiba M, Tanzawa H, Uzawa K.
Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer
Lab Invest
2018
98(8):980-988
PubMed ID: 29855544
DOI: 10.1038/s41374-018-0070-3
|
|
16207
Akihiro Ito, Mitsuhiko Ohta, Yukinari Kato, Shunko Inada, Toshio Kato , Susumu Nakata, Yasushi Yatabe, Mitsuo Goto, Norio Kaneda , Kenichi Kurita, Hayao Nakanishi, Kenji Yoshida
A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green-Labeled Podoplanin Antibody
Technol Cancer Res Treat
2018
1533033818767936.
PubMed ID: 29649929
DOI: 10.1177/1533033818767936
|
|
10044
Ohkoshi E, Umemura N.
Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells.
Int. J. Oncol.
2017
50:387-395
PubMed ID: 28035370
DOI: 10.3892/ijo.2016.3821
|
|
10148
Takahara T, Kasamatsu A, Yamatoji M, Iyoda M, Kasama H, Saito T, Takeuchi S, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Exp. Cell Res.
2017
352:357-363
PubMed ID: 28237246
DOI: 10.1016/j.yexcr.2017.02.026
|
|
10191
Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
Biochem. Biophys. Res. Commun.
2017
486:385-390
PubMed ID: 28315328
DOI: 10.1016/j.bbrc.2017.03.050
|
|
10197
Sakagami H, Okudaira N, Masuda Y, Amano O, Yokose S, Kanda Y, Suguro M, Natori T, Oizumi H, Oizumi T.
Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.
Anticancer Res.
2017
37:1023-1029
PubMed ID: 28314260
DOI: 10.21873/anticanres.11412
|
|
10201
Sakagami H, Masuda Y, Tomomura M, Yokose S, Uesawa Y, Ikezoe N, Asahara D, Takao K, Kanamoto T, Terakubo S, Kagaya H, Nakashima H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Chalcones.
Anticancer Res.
2017
37:1091-1098
PubMed ID: 28314269
DOI: 10.21873/anticanres.11421
|
|
10206
Shimozu Y, Kimura Y, Esumi A, Aoyama H, Kuroda T, Sakagami H, Hatano T.
Ellagitannins of Davidia involucrata. I. Structure of Davicratinic Acid A and Effects of Davidia Tannins on Drug-Resistant Bacteria and Human Oral Squamous Cell Carcinomas.
Molecules
2017
22:
PubMed ID: 28294988
DOI: 10.3390/molecules22030470
|
|
10241
Saijo R, Sekiya H, Tamai E, Kurihara KI, Maki J, Sakagami H, Kawase M.
A Novel Methodology for Synthesis of 1,5,6-Trisubstituted 2(1H)-Pyrazinones of Biological Interest.
Chem. Pharm. Bull.
2017
65:365-372
PubMed ID: 28381677
DOI: 10.1248/cpb.c16-00830
|
|
10386
Suzuki R, Sakagami H, Amano S, Fukuchi K, Sunaga K, Kanamoto T, Terakubo S, Nakashima H, Shirataki Y, Tomomura M, Masuda Y, Yokose S, Tomomura A, Watanabe H, Okawara M, Matahira Y.
Evaluation of Biological Activity of Mastic Extracts Based on Chemotherapeutic Indices.
In Vivo
2017
31:591-598
PubMed ID: 28652425
DOI: 10.21873/invivo.11099
|
|
10576
Sakagami H, Uesawa Y, Masuda Y, Tomomura M, Yokose S, Miyashiro T, Murai J, Takao K, Kanamoto T, Terakubo S, Kagaya H, Nakashima H, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of Newly Synthesized Piperic Acid Esters.
Anticancer Res.
2017
37:6161-6168
PubMed ID: 29061797
DOI: 10.21873/anticanres.12065
|
|
11036
Increased Expression of CD44v9, A Cancer Stem Cell Marker, in Head And Neck Squamous Cell Carcinoma Cells after Irradiation
Int J Cancer Oncol
2017
4: 225- 230
DOI: 10.15436/2377-0902.17.1628
|
|
6024
Hamada M, Kameyama H, Iwai S, Yura Y.
Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells.
Cell Death Discov
2017
3:17047
PubMed ID: 29109864
DOI: 10.1038/cddiscovery.2017.47
|
|
14254
Koshizuka K, Nohata N, Hanazawa T, Kikkawa N, Arai T, Okato A, Fukumoto I, Katada K, Okamoto Y, Seki N.
Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs
Oncotarget
2017
8(18):30288-30304
PubMed ID: 28415821
DOI: 10.18632/oncotarget.16327
|
|
14365
Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer
Cancer Sci
2017
108(8):1681-1692
PubMed ID: 28612520
DOI: 10.1111/cas.13298
|
|
7096
Yoshino F, Yoshida A, Toyama T, Wada-T S, Takahashi S
α-Glucosyl hesperidin suppressed the exacerbation of 5-fluorouracil-induced oral mucositis in the hamster cheek pouch.
J Functional Foods
2016
21:223-231
DOI: 10.1016/j.jff.2015.12.008
|
|
9584
Hino S, Nishiyama A, Matsuta T, Horie N, Shimoyama T, Tanaka S, Sakagami H.
Quest for Cells Responsible for Age-related Increase of Salivary Glycine and Proline.
In Vivo
2016
30:91-7
PubMed ID: 26912818
|
|
9616
Kitajima D, Kasamatsu A, Nakashima D, Miyamoto I, Kimura Y, Saito T, Suzuki T, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Tie2 Regulates Tumor Metastasis of Oral Squamous Cell Carcinomas.
J Cancer
2016
7:600-7
PubMed ID: 27053959
DOI: 10.7150/jca.13820
|
|
9630
Kimura Y, Kasamatsu A, Nakashima D, Yamatoji M, Minakawa Y, Koike K, Fushimi K, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
ARNT2 Regulates Tumoral Growth in Oral Squamous Cell Carcinoma.
J Cancer
2016
7:702-10
PubMed ID: 27076852
DOI: 10.7150/jca.14208
|
|
9654
Kumasaka A, Matsumoto N, Mukae S, Kitano T, Noguchi H, Ohki H, Komiyama K, Ando T.
Rapid and Specific Screening Assay for KRAS Oncogene Mutation by a Novel Gene Amplification Method.
Anticancer Res.
2016
36:1571-9
PubMed ID: 27069133
|
|
9676
Shibata A, Ibaragi S, Mandai H, Tsumura T, Kishimoto K, Okui T, Hassan NM, Shimo T, Omori K, Hu GF, Takashiba S, Suga S, Sasaki A.
Synthetic Terrein Inhibits Progression of Head and Neck Cancer by Suppressing Angiogenin Production.
Anticancer Res.
2016
36:2161-8
PubMed ID: 27127118
|
|
9694
Harada K, Ferdous T, Harada T, Ueyama Y.
Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Int. J. Oncol.
2016
49:276-84
PubMed ID: 27210058
DOI: 10.3892/ijo.2016.3523
|
|
9762
Tachibana H, Sho R, Takeda Y, Zhang X, Yoshida Y, Narimatsu H, Otani K, Ishikawa S, Fukao A, Asao H, Iino M.
Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target.
PLoS ONE
2016
11:e0159693
PubMed ID: 27441818
DOI: 10.1371/journal.pone.0159693
|
|
9808
Tomikoshi Y, Nomura M, Okudaira N, Sakagami H, Wakabayashi H.
Enhancement of Cytotoxicity of Three Apoptosis-inducing Agents Against Human Oral Squamous Cell Carcinoma Cell Line by Benzoxazinotropone.
In Vivo
2016
30:645-50
PubMed ID: 27566085
|
|
9851
Masui A, Hamada M, Kameyama H, Wakabayashi K, Takasu A, Imai T, Iwai S, Yura Y.
Autophagy as a Survival Mechanism for Squamous Cell Carcinoma Cells in Endonuclease G-Mediated Apoptosis.
PLoS ONE
2016
11:e0162786
PubMed ID: 27658240
DOI: 10.1371/journal.pone.0162786
|
|
9892
Uesawa Y, Sakagami H, Kagaya H, Yamashita M, Takao K, Sugita Y.
Quantitative Structure-cytotoxicity Relationship of 3-Benzylidenechromanones.
Anticancer Res.
2016
36:5803-5812
PubMed ID: 27793902
DOI: 10.21873/anticanres.11164
|
|
9896
Suzuki R, Matsushima Y, Okudaira N, Sakagami H, Shirataki Y.
Cytotoxic Components Against Human Oral Squamous Cell Carcinoma Isolated from Andrographis paniculata.
Anticancer Res.
2016
36:5931-5935
PubMed ID: 27793918
DOI: 10.21873/anticanres.11180
|
|
9911
Fukuchi K, Okudaira N, Adachi K, Odai-Ide R, Watanabe S, Ohno H, Yamamoto M, Kanamoto T, Terakubo S, Nakashima H, Uesawa Y, Kagaya H, Sakagami H.
Antiviral and Antitumor Activity of Licorice Root Extracts.
In Vivo
2016
30:777-785
PubMed ID: 27815461
DOI: 10.21873/invivo.10994
|
|
6032
Tada H, Shimizu T, Nagaoka I, Takada H.
Vitamin D3 analog maxacalcitol (OCT) induces hCAP-18/LL-37 production in human oral epithelial cells.
Biomed Res
2016
37(3):199-205
PubMed ID: 27356607
DOI: 10.2220/biomedres.37.199
|
|
6033
Shimizu T, Kawai J, Ouchi K, Kikuchi H, Osima Y, Hidemi R.
Agarol, an ergosterol derivative from Agaricus blazei, induces caspase-independent apoptosis in human cancer cells.
Int J Oncol
2016
48(4):1670-8
PubMed ID: 26893131
DOI: 10.3892/ijo.2016.3391
|
|
6036
Suzuki T, Kasamatsu A, Miyamoto I, Saito T, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H, Uzawa K.
Overexpression of TMOD1 is associated with enhanced regional lymph node metastasis in human oral cancer.
Int J Oncol.
2016
48(2):607-12
PubMed ID: 26718916
DOI: 10.3892/ijo.2015.3305
|
|
6042
Unozawa M, Kasamatsu A, Higo M, Fukumoto C, Koyama T, Sakazume T, Nakashima D, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa
Cavin-2 in oral cancer: A potential predictor for tumor progression.
Mol Carcinog
2016
55(6):1037-47
PubMed ID: 26086332
DOI: 10.1002/mc.22347
|
|
14162
Yamali C, Gul HI, Sakagami H, Supuran CT.
Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases
J Enzyme Inhib Med Chem
2016
31(sup4):125-131
PubMed ID: 27594305
DOI: 10.1080/14756366.2016.1221825
|
|
14178
Orabi MA, Taniguchi S, Sakagami H, Yoshimura M, Amakura Y, Hatano T.
Hydrolyzable Tannins of Tamaricaceous Plants. 7.1 Structures and Cytotoxic Properties of Oligomeric Ellagitannins from Leaves of Tamarix nilotica and Cultured Tissues of Tamarix tetrandra
J Nat Prod
2016
79(4):984-95
PubMed ID: 26938659
DOI: 10.1021/acs.jnatprod.5b01065
|
|
7109
Miyazaki Y, Yoshida N, Nozaki T, Inoue H, Kikuchi K, Kusama K.
Telomerase activity in the occurrence and progression of oral squamous cell carcinoma.
J Oral Sci
2015
57:295-303
PubMed ID: 26666852
DOI: 10.2334/josnusd.57.295
|
|
7175
Ohnishi Y, Yasui H, Kakudo K, Nozaki M.
Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.
Int. J. Oncol.
2015
47:2165-72
PubMed ID: 26497980
DOI: 10.3892/ijo.2015.3215
|
|
7196
Uesawa Y, Sakagami H, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Yahagi H, Takao K, Sugita Y.
Quantitative Structure-Cytotoxicity Relationship of 3-Styryl-2H-chromenes.
Anticancer Res.
2015
35:5299-307
PubMed ID: 26408690
|
|
5422
Sakagami H, Uesawa Y, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Sugita Y5.
Quantitative Structure-Cytotoxicity Relationship of Oleoylamides.
Anticancer Res
2015
5(10):5341-51
PubMed ID: 26408695
|
|
6043
Sakagami H, Shimada C, Kanda Y, Amano O, Sugimoto M, Ota S, Soga T, Tomita M, Sato A, Tanuma SI, Takao K, Sugita Y.
Effects of 3-styrylchromones on metabolic profiles and cell death in oral squamous cell carcinoma cells.
Toxicol Rep
2015
2:1281-1290
PubMed ID: 28962471
DOI: 10.1016/j.toxrep.2015.09.009
|
|
6044
Kasama H et al
Adenosine A2b receptor promotes progression of human oral cancer.
BMC Cancer
2015
15:563
PubMed ID: 26228921
DOI: 10.1186/s12885-015-1577-2
|
|
6051
Okamoto A et al
Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.
PLoS One
2015
10(11):e0142252
PubMed ID: 26554377
DOI: 10.1371/journal.pone.0142252
|
|
6052
Saito T et al
Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
PLoS One
2015
10(9):e0137923
PubMed ID: 26378920
DOI: 10.1371/journal.pone.0137923
|
|
6053
Miyamoto I et al
Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.
Biochem Biophys Rep
2015
3:26-31
PubMed ID: 29124166
DOI: 10.1016/j.bbrep.2015.07.008
|
|
6058
Shida-Sakazume T et al
Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
PLoS One.
2015
10(3):e0120143
PubMed ID: 25803864
DOI: 10.1371/journal.pone.0120143
|
|
15042
Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer
Cancer Med
2015
4(5):759-69
PubMed ID: 25644496
DOI: 10.1002/cam4.418
|
|
10985
Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Celis E, Harabuchi Y, Kobayashi H.
Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
Sci Rep
2015
5:16280
PubMed ID: 26538233
DOI: 10.1038/srep16280
|
|
6023
Watanabe M, Ohnishi Y, Inoue H, Wato M, Tanaka A, Kakudo K, Nozaki M.
NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma.
Oncol Lett
2014
7(1):35-40
PubMed ID: 24348816
DOI: 10.3892/ol.2013.1690
|
|
6006
Ohnishi Y, Watanabe M, Yasui H, Kakudo K.
Effects of epidermal growth factor on the invasive activity and cytoskeleton of oral squamous cell carcinoma cell lines.
Oncol Lett
2014
7(5):1439-1442
PubMed ID: 24765152
DOI: 10.3892/ol.2014.1946
|
|
5916
Garcia-Contreras R, Scougall-Vilchis RJ, Contreras-Bulnes R, Kanda Y, Nakajima H, Sakagami H
Cytotoxicity and pro-inflammatory action of chemo-mechanical caries-removal agents against oral cells.
In Vivo
2014
28(4):549-56
PubMed ID: 24982221
|
|
5859
Miyamoto C, Maehata Y, Motohashi K, Ozawa S, Ikoma T, Hidaka K, Wada-Takahashi S, Takahashi SS, Yoshino F, Yoshida A, Kubota E, Hata R, Lee MC.
Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.
Biomed Res.
2014
35(6):381-8
PubMed ID: 25743344
DOI: 10.2220/biomedres.35.381
|
|
5807
Garcia-Contreras R, Scougall-Vilchis RJ, Contreras-Bulnes R, Kanda Y, Nakajima H, Sakagami H.
Effects of TiO2 nano glass ionomer cements against normal and cancer oral cells.
In Vivo
2014
28(5):895-907
PubMed ID: 25189906
|
|
5778
Ishige S, Kasamatsu A, Ogoshi K, Saito Y, Usukura K, Yokoe H, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer.
Mol Carcinog
2014
53(7):557-65
PubMed ID: 23371469
DOI: 10.1002/mc.22007
|
|
5659
Shimada C, Uesawa Y, Ishii-Nozawa R, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Sugita Y, Sakagami H.
Quantitative structure-cytotoxicity relationship of 3-styrylchromones.
Anticancer Res
2014
34(10):5405-11
PubMed ID: 25275035
|
|
5605
Iizuka S, Oridate N, Nashimoto M, Fukuda S, Tamura M.
Growth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencing.
PLoS One
2014
9(12):e114121
PubMed ID: 25437003
DOI: 10.1371/journal.pone.0114121
|
|
5544
Shimada C, Uesawa Y, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Saito T, Sugita Y, Sakagami H.
Quantitative structure-cytotoxicity relationship of phenylpropanoid amides.
Anticancer Res
2014
34(7):3543-8
PubMed ID: 24982367
|
|
5337
Shimada C, Uesawa Y, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, Nakashima H, Takao K, Miyashiro T, Sugita Y, Sakagami H.
Quantitative structure-cytotoxicity relationship of piperic acid amides.
Anticancer Res
2014
34(9):4877-84
PubMed ID: 25202069
|
|
5315
Sekine S, Shimodaira C, Uesawa Y, Kagaya H, Kanda Y, Ishihara M, Amano O, Sakagami H, Wakabayashi H.
Quantitative structure-activity relationship analysis of cytotoxicity and anti-UV activity of 2-aminotropones.
Anticancer Res
2014
4(4):1743-50
PubMed ID: 24692705
|
|
5307
Kumai T, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H.
Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor.
J Transl Med
2014
12:265
PubMed ID: 25240937
DOI: 10.1186/s12967-014-0265-3
|
|
5122
Iida S, Shimada J, Sakagami H.
Cytotoxicity induced by docetaxel in human oral squamous cell carcinoma cell lines.
In Vivo
2013
27(3):321-32
PubMed ID: 23606687
|
|
5110
Ohno H, Araho D, Uesawa Y, Kagaya H, Ishihara M, Sakagami H, Yamamoto M.
Evaluation of cytotoxiciy and tumor-specificity of licorice flavonoids based on chemical structure.
Anticancer Res
2013
33(8):3061-8
PubMed ID: 23898061
|
|
5057
Tsujikawa T, Yaguchi T, Ohmura G, Ohta S, Kobayashi A, Kawamura N, Fujita T, Nakano H, Shimada T, Takahashi T, Nakao R, Yanagisawa A, Hisa Y, Kawakami Y.
Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Int J Cancer.
2013
132(12):2755-66
PubMed ID: 23180648
DOI: 10.1002/ijc.27966
|
|
6070
Yamamoto A, Kasamatsu A, Ishige S, Koike K, Saito K, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases.
J Cancer Res Clin Oncol
2013
139(4):533-42
PubMed ID: 23207790
DOI: 10.1007/s00432-012-1356-2
|
|
6071
Kondoh M, Ohga N, Akiyama K, Hida Y, Maishi N, Towfik AM, Inoue N, Shindoh M, Hida K.
Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment.
PLoS One
2013
8(11):e80349
PubMed ID: 24260373
DOI: 10.1371/journal.pone.0080349
|
|
6072
Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H, Tanzawa H.
Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
PLoS One
2013
8(2):e56381
PubMed ID: 23418564
DOI: 10.1371/journal.pone.0056381
|
|
6076
Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Kinesin family member 4A: a potential predictor for progression of human oral cancer.
PLoS One. 2
2013
8(12):e85951
PubMed ID: 24386490
DOI: 10.1371/journal.pone.0085951
|
|
6077
Mikami T, Hada T, Chosa N, Ishisaki A, Mizuki H, Takeda Y. Author information
Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.
J Oral Pathol Med
2013
42(2):133-9
PubMed ID: 22672247
DOI: 10.1111/j.1600-0714.2012.01182.x
|
|
6078
Hotta H, Hamamura K, Yamashita K, Shibuya H, Tokuda N, Hashimoto N, Furukawa K, Yamamoto N, Hattori H, Toyokuni S, Ueda M, Furukawa K.
Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x.
Glycoconj J
2013
30(6):585-97
PubMed ID: 23242548
DOI: 10.1007/s10719-012-9458-2
|
|
6081
Kimura R, Kasamatsu A, Koyama T, Fukumoto C, Kouzu Y, Higo M, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation.
BMC Cancer
2013
13:555
PubMed ID: 24261884
DOI: 10.1186/1471-2407-13-555
|
|
6083
Kumai T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Celis E, Kobayashi H.
EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy.
Br J Cancer
2013
109(8):2155-66
PubMed ID: 24045666
DOI: 10.1038/bjc.2013.577
|
|
15086
Katase N, Lefeuvre M, Tsujigiwa H, Fujii M, Ito S, Tamamura R, Buery RR, Gunduz M, Nagatsuka H.
Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells
Oncol Rep
2013
29(4):1349-55
PubMed ID: 23354949
DOI: 10.3892/or.2013.2251
|
|
7722
Kusumoto T, Hamada T, Yamada N, Nagata S, Kanmura Y, Houjou I, Kamikawa Y, Yonezawa S, Sugihara K.
Comprehensive epigenetic analysis using oral rinse samples: a pilot study.
J. Oral Maxillofac. Surg.
2012
70:1486-94
PubMed ID: 21821326
DOI: 10.1016/j.joms.2011.04.021
|
|
6087
Miyazaki Y, Inoue H, Kikuchi K, Ochiai K, Kusama K.
Activation-induced cytidine deaminase mRNA expression in oral squamous cell carcinoma-derived cell lines is upregulated by inflammatory cytokines.
J Oral Sci
2012
54(1):71-5
PubMed ID: 22466889
DOI: 10.2334/josnusd.54.71
|
|
6088
Baba T, Kawaguchi M, Fukushima T, Sato Y, Orikawa H, Yorita K, Tanaka H, Lin CY, Sakoda S, Kataoka H.
Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
J Pathol
2012
228(2):181-92
PubMed ID: 22262311
DOI: 10.1002/path.3993
|
|
6089
Inoue H, Miyazaki Y, Kikuchi K, Yoshida N, Ide F, Ohmori Y, Tomomura A, Sakashita H, Kusama K.
Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
J Oral Sci
2012
54(3):241-50
PubMed ID: 23047035
DOI: 10.2334/josnusd.54.241
|
|
6095
Katase N, Lefeuvre M, Gunduz M, Gunduz E, Beder LB, Grenman R, Fujii M, Tamamura R, Tsujigiwa H, Nagatsuka H.
Absence of Dickkopf (Dkk)-3 protein expression is correlated with longer disease-free survival and lower incidence of metastasis in head and neck squamous cell carcinoma.
Oncol Lett
2012
3(2):273-280
PubMed ID: 22740894
DOI: 10.3892/ol.2011.473
|
|
6098
Inoue H, Miyazaki Y, Kikuchi K, Yoshida N, Ide F, Ohmori Y, Tomomura A, Sakashita H, Kusama K.
Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity.
Tumour Biol
2012
33(1):183-94
PubMed ID: 22081310
DOI: 10.1007/s13277-011-0261-7
|
|
15671
Harada T, Harada K, Ueyama Y.
The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma
Int J Oncol
2012
41(2):565-72
PubMed ID: 22664937
DOI: 10.3892/ijo.2012.1501
|
|
7601
Uesawa Y, Mohri K, Kawase M, Ishihara M, Sakagami H.
Quantitative structure-activity relationship (QSAR) analysis of tumor-specificity of 1,2,3,4-tetrahydroisoquinoline derivatives.
Anticancer Res.
2011
31:4231-8
PubMed ID: 22199286
|
|
7691
Susuki D, Kimura S, Naganuma S, Tsuchiyama K, Tanaka T, Kitamura N, Fujieda S, Itoh H.
Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma.
Cancer Sci.
2011
102:2164-71
PubMed ID: 21899661
DOI: 10.1111/j.1349-7006.2011.02096.x
|
|
6109
Inoue H, Ohnishi Y, Nakajima M, Kakudo K, Nozaki M.
A novel function of EpCAM in oral squamous cell carcinoma cells under anchorage-independent conditions.
Int J Oncol
2011
39(6):1401-5
PubMed ID: 21785818
DOI: 10.3892/ijo.2011.1137
|
|
6112
lHiroshi Inoue et al
Effects of a gamma secretase inhibitor on the proliferation and invasiveness of oral squamous cell carcinoma cell lines
Asian Journal of Oral and Maxillofacial Surgery
2011
23:1-6
DOI: 10.1016/j.ajoms.2010.10.001
|
|
6116
Zhang T, Hamada K, Hyodo M, Itoh H, Tani K, Goda H, Nakashiro K, Hamakawa H.
Gene therapy for oral squamous cell carcinoma with IAI.3B promoter-driven oncolytic adenovirus-infected carrier cells.
Oncol Rep
2011
25(3):795-802
PubMed ID: 21206983
DOI: 10.3892/or.2010.1130
|
|
6118
Suguru Dateoka, Yuichi Ohnishi, Kenji Kakudo
Synergistic anti-tumor effect of CDDP with CRM197, a specific inhibitor of HB-EGF, in oral cancer
Journal of Osaka Dental University
2011
45：31-36
DOI: 10.18905/jodu.45.1_31
|
|
8085
Sakagami H, Zhou L, Kawano M, Thet MM, Tanaka S, Machino M, Amano S, Kuroshita R, Watanabe S, Chu Q, Wang QT, Kanamoto T, Terakubo S, Nakashima H, Sekine K, Shirataki Y, Zhang CH, Uesawa Y, Mohri K, Kitajima M, Oizumi H, Oizumi T.
Multiple biological complex of alkaline extract of the leaves of Sasa senanensis Rehder.
In Vivo
2010
24:735-43
PubMed ID: 20952742
|
|
8383
Uemura N, Kodama S, Nomi N, Okamoto T, Suzuki M.
Correlation between anti-survivin antibody and survivin mRNA expression in head and neck cancer patients.
Acta Otolaryngol.
2010
130:959-65
PubMed ID: 20100132
DOI: 10.3109/00016480903555416
|
|
5611
Wakabayashi H, Narita T, Suga A, Sakagami H.
Hormetic response of cultured normal and tumor cells to 2-aminotropone derivatives.
In Vivo
2010
24(1):39-44
PubMed ID: 20133973
|
|
6120
Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K.
NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Biochem Biophys Res Commun
2010
391(4):1785-91
PubMed ID: 20045673
DOI: 10.1016/j.bbrc.2009.12.156
|
|
6122
Nomi N, Kodama S, Suzuki M.
Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway.
Oncol Rep
2010
24(1):225-31
PubMed ID: 20514466
DOI: 10.3892/or_00000850
|
|
6123
Yuji Miyazaki et al
Association of butyric acid produced by periodontopathic bacteria with progression of oral cancer
J Cancer Sci Ther
2010
2(2) :26-32
|
|
13818
Kikuji Yamashita, Shine-Od Dalkhsuren, Tatsuo Ishikawa, Kaori Sumida, Jun Ishibashi, Hiroyoshi Hosokawa, Akemichi Ueno, Fumio Nasu, Seiichiro Kitamura
Far Infrared Ray Radiation Inhibits the Proliferation of A549, HSC3 and Sa3 Cancer Cells through Enhancing the Expression of ATF3 Gene
Journal of Electromagnetic Analysis and Applications
2010
2:382-394
DOI: 10.4236/jemaa.2010.26050
|
|
6127
Hatano H, Takekawa F, Hashimoto K, Ishihara M, Kawase M, Qing C, Qin-Tao W, Sakagami H.
Tumor-specific cytotoxic activity of 1,2,3,4-tetrahydroisoquinoline derivatives against human oral squamous cell carcinoma cell lines.
Anticancer Res
2009
29(8):3079-86
PubMed ID: 19661319
|
|
6128
Takano A, Hashimoto K, Ogawa M, Koyanagi J, Kurihara T, Wakabayashi H, Kikuchi H, Nakamura Y, Motohashi N, Sakagami H, Yamamoto K, Tanaka A.
Tumor-specific cytotoxicity and type of cell death induced by naphtho[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: relationship to electronic structure.
Anticancer Res
2009
29(1):455-64
PubMed ID: 19331186
|
|
6129
Narita T, Suga A, Kobayashi M, Hashimoto K, Sakagami H, Motohashi N, Kurihara T, Wakabayashi H.
Tumor-specific cytotoxicity and type of cell death induced by benzo[b]cyclohept[e][1,4]oxazine and 2-aminotropone derivatives.
Anticancer Res
2009
29(4):1123-30
PubMed ID: 19414354
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
|
6136
Okamura M, Shimada J, Sakagami H.
Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Anticancer Res
2008
28(1A):253-9
PubMed ID: 18383853
|
|
6138
Murayama H, Miyahara K, Wakabayashi H, Kurihara T, Hashimoto K, Amano O, Kikuchi H, Nakamura Y, Kanda Y, Kunii S, Motohashi N, Sakagami H.
Tumor-specific cytotoxicity and type of cell death induced by benzocycloheptoxazines in human tumor cell lines.
Anticancer Res
2008
28(2A):1069-78
PubMed ID: 18507056
|
|
6141
Nakamura E, Kozaki K, Tsuda H, Suzuki E, Pimkhaokham A, Yamamoto G, Irie T, Tachikawa T, Amagasa T, Inazawa J, Imoto I.
Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.
Cancer Sci
2008
99(7):1390-400
PubMed ID: 18452558
DOI: 10.1111/j.1349-7006.2008.00838.x
|
|
6143
Sekine T, Takahashi J, Nishishiro M, Arai A, Wakabayashi H, Kurihara T, Kobayashi M, Hashimoto K, Kikuchi H, Katayama T, Kanda Y, Kunii S, Motohashi N, Sakagami H.
Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines.
Anticancer Res.
2007
27(1A):133-43
PubMed ID: 17352225
|
|
6148
Akatsu Y, Ohshima N, Yamagishi Y, Nishishiro M, Wakabayashi H, Kurihara T, Kikuchi H, Katayama T, Motohashi N, Shoji Y, Nakashima H, Sakagami H.
Apoptosis-inducing activity of trihaloacetylazulenes against human oral tumor cell lines.
Anticancer Res
2006
26(3A):1917-23
PubMed ID: 16827125
|
|
6150
Ichwan SJ, Yamada S, Sumrejkanchanakij P, Ibrahim-Auerkari E, Eto K, Ikeda MA.
Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells.
Oncogene
2006
25(8):1216-24
PubMed ID: 16247456
DOI: 10.1038/sj.onc.1209158
|
|
6152
Wakabayashi H, Nishishiro M, Arikawa S, Hashimoto K, Kikuchi H, Nishikawa H, Kurihara T, Terakubo S, Shoji Y, Nakashima H, Motohashi N, Sakagami H.
Cytotoxic activity of azulenequinones against human oral tumor cell lines.
Anticancer Res
2005
25(1A):305-12
PubMed ID: 15816552
|
Back
Top
CELL BANK Website
